Vimpat (Lacosamide Tablets) and Hepatic impairment
Result of checking the interaction of drug Vimpat (Lacosamide Tablets) and disease Hepatic impairment for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Patients with mild to moderate hepatic impairment should be observed closely during lacosamide dose titration. A maximum dose of 300 mg/day is recommended for these patients. Lacosamide has not been evaluated in patients with severe hepatic impairment, so its use is not recommended in this group of patients.
Generic Name: lacosamide
Brand Name: Vimpat
Synonyms: Vimpat
Vimpat (Lacosamide Tablets) - zaburzenia czynności wątroby 
Vimpat (Lacosamide Tablets) - insuficiência hepática 
Vimpat (Lacosamide Tablets) - gangguan hati 
Vimpat (Lacosamide Tablets) - gangguan hati 
Vimpat (Lacosamide Tablets) - insufficienza epatica 
Vimpat (Lacosamide Tablets) - insuffisance hépatique 
Vimpat (Lacosamide Tablets) - Leberfunktionsstörung 
Vimpat (Lacosamide Tablets) - deterioro hepático 
Vimpat (Lacosamide Tablets) - печеночная недостаточность 
Vimpat (Lacosamide Tablets) - karaciğer yetmezliği 
Vimpat (Lacosamide Tablets) - اختلال كبدي 
Vimpat (Lacosamide Tablets) - 肝功能不全